Philadelphia (1)

Sherbrooke (1)

LPL Deficiency (1)

Withdrawn (1)

phase 2 (1)

UniQure Biopharma B.V. (1)

Chiesi Farmaceutici S.p.A. (1)

alipogene tiparvovec (1)

cyclosporins (1)

mycophenolate mofetil (1)

prednisolone (1)

drug (1)

Industry (1)

Interventional (1)

lpl deficiency

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Withdrawn

Aug 14, 2017